Plain-English translation of NCT06464731 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a minimally invasive catheter procedure—where doctors thread a thin tube through blood vessels to physically remove a clot from the brain—works better than standard medications alone for treating mild strokes. You would be randomly assigned to receive either the catheter procedure or the best available medications. The study wants to understand if the procedure is both safe and more effective for patients with mild symptoms caused by large vessel blockages.
Many mild strokes are currently treated with medications alone, but doctors aren't sure whether removing the clot directly with a catheter procedure might help patients recover better. This study aims to find the best treatment approach for this specific group of patients.
You likely qualify if…
You likely don't qualify if…
If you enroll, you'll be randomly assigned to one of two groups. One group will receive a catheter procedure where doctors use special instruments to remove the clot from your brain artery. The other group will receive standard medications such as blood thinners or clot-busting drugs. Either way, you'll receive the best medical care available, and your recovery will be carefully monitored with imaging and neurological assessments over time to track how well you improve.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
China